• Novartis AG EPS for the quarter ending December 31, 2024 was $1.40, a 65.52% decline year-over-year.
• Novartis AG 2024 annual EPS was $5.87, a 17.32% decline from 2023.
• Novartis AG 2023 annual EPS was $7.1, a 123.97% increase from 2022.
• Novartis AG 2022 annual EPS was $3.17, a 70.18% decline from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.